Mark Watling
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
- Physiology 15
- Alzheimer's disease research and treatments 15
-
- Dementia and Cognitive Impairment Research 5
- Co-authors
- Bruno P. Imbimbo (16 shared papers)Francesco Panza (6 shared papers)Madia Lozupone (6 shared papers)Stefania Ippati (6 shared papers)Vincenzo Solfrizzi (3 shared papers)A. Knight (3 shared papers)Claudia Balducci (4 shared papers)Alexander Fisher (2 shared papers)
- Journals
- Expert Opinion on Investigational Drugs (3 papers)Alzheimer s & Dementia (3 papers)Expert Opinion on Drug Discovery (2 papers)Annals of the Rheumatic Diseases (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- ItalyUnited KingdomBelgium
In The Last Decade
Mark Watling
28 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 93
- Biological Psychiatry 60
- Physiology 391
- Neurology 113
- Anesthesiology and Pain Medicine 56
- Immunology 213
Countries citing papers authored by Mark Watling
This map shows the geographic impact of Mark Watling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Watling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Watling more than expected).
Fields of papers citing papers by Mark Watling
This network shows the impact of papers produced by Mark Watling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Watling. The network helps show where Mark Watling may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Watling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 215 | |
| 2 | 2019 | 134 | |
| 3 | 2019 | 102 | |
| 4 | 2020 | 78 | |
| 5 | 2010 | 51 | |
| 6 | 2019 | 50 | |
| 7 | 2010 | 48 | |
| 8 | 2021 | 47 | |
| 9 | 2022 | 47 | |
| 10 | 2022 | 34 | |
| 11 | 2021 | 34 | |
| 12 | 2020 | 25 | |
| 13 | 2023 | 21 | |
| 14 | 2021 | 20 | |
| 15 | 2022 | 18 | |
| 16 | 2022 | 18 | |
| 17 | 2020 | 16 | |
| 18 | 2021 | 14 | |
| 19 | 2020 | 13 | |
| 20 | 2017 | 13 |
About Mark Watling
Mark Watling is a scholar working on Physiology, Psychiatry and Mental health, Pharmacology, Neurology and Neurology, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (5 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Pain Management and Opioid Use (2 papers), Computational Drug Discovery Methods (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Biological Psychiatry (60 citations), Physiology (391 citations), Neurology (113 citations), Anesthesiology and Pain Medicine (56 citations) and Immunology (213 citations). Mark Watling has collaborated with scholars based in Italy, United Kingdom and Belgium. Frequent co-authors include Bruno P. Imbimbo, Francesco Panza, Madia Lozupone, Stefania Ippati, Vincenzo Solfrizzi, A. Knight, Claudia Balducci, Alexander Fisher, Stevan Shaw and Dominique Baeten. Their work appears in journals such as Expert Opinion on Investigational Drugs, Alzheimer s & Dementia, Expert Opinion on Drug Discovery, Annals of the Rheumatic Diseases and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.